Xiao-Feng Dong

机构：The People's Hospital of Guangxi Zhuang Autonomous Region

发表论文 30 篇 · 总被引 79 次 · h-index 7

代表论文

• AST to ALT ratio as a prospective risk predictor for liver cirrhosis in patients with chronic HBV infection (2024 · European Journal of Gastroenterology & Hepatology · 被引 16)
• Combining bulk and scRNA‐seq to explore the molecular mechanisms governing the distinct efferocytosis activities of a macrophage subpopulation in PDAC (2024 · Journal of Cellular and Molecular Medicine · 被引 11)
• Inactivation Effect of Low-Temperature Plasma on <italic>Pseudomonas aeruginosa</italic> for Nosocomial Anti-Infection (2015 · IEEE Transactions on Plasma Science · 被引 10)
• Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response (2025 · Metabolism · 被引 9)
• Preoperative albumin-alkaline phosphatase ratio affects the prognosis of patients undergoing hepatocellular carcinoma surgery (2023 · Cancer Biomarkers · 被引 8)
• Prognostic value of radiological and pathological complete response following immune-based conversion therapy in patients with unresectable hepatocellular carcinoma (GUIDANCE004) (2025 · JHEP Reports · 被引 7)